BENDAMUSTINE 180 mg/4 ml DRL


Concentrate for solution for infusion
scheduling status
S4
registration number
56/26/0216
What BENDAMUSTINE 180 mg/4 ml DRL contains
Bendamustine hydrochloride.
other ingredients
Butylhydroxytoluene Macrogol 300.
Therapeutic classification
A 26 Cytostatic agents.
© 2026 SAHPRA. ALL RIGHTS RESERVED